Minerva Neurosciences (NERV) Other Non-Current Liabilities (2014 - 2026)
Minerva Neurosciences (NERV) recorded Other Liabilities of $292.69 million in Q2 2026, up 387.8% from $60 million a year earlier but down 13.6% from the prior quarter.
Minerva Neurosciences (NERV) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Minerva Neurosciences reported Other Liabilities of $231.46 million, up 285.8% from FY2024.
- Annual Other Liabilities has a four-year compound annual growth rate of 36.7% (FY2021 to FY2025).
- Across earlier years, Other Liabilities came in at $60 million in FY2024 (-26.8%), $82.02 million in FY2023 (+11.2%), $73.73 million in FY2022 (+11.2%) and $66.33 million in FY2021.
- Quarterly Other Liabilities has ranged from $60 million in Q3 2024 to $338.6 million in Q1 2026 over the past five years.
- On a year-over-year basis, Other Liabilities has increased for three consecutive quarters, with growth averaging 128.3% over the last eight quarters.
- Peak year-over-year performance for Other Liabilities in the last five years was growth of 464.3% in Q1 2026, against a decline of 30.7% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $338.6 million (Q1 2026), $231.46 million (Q4 2025) and $60 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Minerva Neurosciences | 121.62 Mn | -126.30 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 292.69 Mn |
| Mar 31, 2026 | 338.60 Mn |
| Dec 31, 2025 | 231.46 Mn |
| Sep 30, 2025 | 60.00 Mn |
| Jun 30, 2025 | 60.00 Mn |
| Mar 31, 2025 | 60.00 Mn |
| Dec 31, 2024 | 60.00 Mn |
| Sep 30, 2024 | 60.00 Mn |
| Jun 30, 2024 | 86.58 Mn |
| Mar 31, 2024 | 84.27 Mn |
| Dec 31, 2023 | 82.02 Mn |
| Sep 30, 2023 | 79.83 Mn |
| Jun 30, 2023 | 77.74 Mn |
| Mar 31, 2023 | 75.71 Mn |
| Dec 31, 2022 | 73.73 Mn |
| Sep 30, 2022 | 71.81 Mn |
| Jun 30, 2022 | 69.93 Mn |
| Mar 31, 2022 | 68.11 Mn |
| Dec 31, 2021 | 66.33 Mn |
| Sep 30, 2021 | 64.59 Mn |
Minerva Neurosciences Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NERV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();